| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 52EG7RFE6Y |
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C24H26N8O2 |
| Molecular Weight | 458.53 |
| AlogP | 2.9 |
| Hydrogen Bond Acceptor | 9.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 117.82 |
| Molecular species | None |
| Aromatic Rings | 4.0 |
| Heavy Atoms | 34.0 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | MAP kinase-activated protein kinase 5 inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Arthritis, Rheumatoid | 2 | D001172 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3545338 |
| FDA SRS | 52EG7RFE6Y |
CONTENTS